Delivery Order SPE2DB22D1106-SPE2DB25FFAX4
- Not listed
- The Defense Logistics Agency awarded a $5,084.04 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Eliquis 5 mg tablets in a 60-count package. This competitively awarded, non-set-aside contract is scheduled for completion by July 25, 2025, with performance to be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,515.37 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages). This competitively awarded, firm fixed-price contract was issued on July 29, 2025, with an ultimate completion date of July 30, 2025. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen Drug...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,827.12 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) under a firm fixed-price contract. The delivery order was awarded on July 30, 2025, with an ultimate completion date of July 31, 2025, and represents a non-competitive, competitively awarded transaction. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $11,794.32 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Eliquis 5 mg tablets (60-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation, requiring completion by July 31, 2025. AmerisourceBergen will fulfill this order from its Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,856.90 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) under a firm fixed price contract. The award, issued on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a non-set-aside, competitively awarded procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical supply...
- The Defense Logistics Agency awarded a delivery order valued at $11,258.62 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages). The contract is a firm fixed price delivery order with an ultimate completion date of July 31, 2025, and was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same municipality. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $45,611.82 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed price delivery order was issued without set-aside provisions and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a standard pharmaceutical procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,137.79 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed-price contract. This non-set-aside award, effective July 31, 2025, with completion targeted for August 1, 2025, represents a child delivery order under AmerisourceBergen's larger prime indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Eliquis 5 mg tablets (60-count) with a ceiling value of $54,937.02 and a completion date of July 30, 2025. This non-set-aside competitive award represents a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $83,800.36 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). This competitive award, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and serves the federal medical supply chain...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFAX4Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $97,535.14 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). This firm fixed-price contract, awarded on July 31, 2025, with completion targeted for August 1, 2025, represents a non-competitive set-aside delivery order issued under DLA's pharmaceutical procurement framework. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location in Conshohocken, PA 19428. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive pharmaceutical support vehicle enables AmerisourceBergen to supply a broad range of medications and medical supplies to support military healthcare systems globally. The supply of Eliquis, an anticoagulant medication, supports the Defense Health Agency, U.S. Coast Guard, and other federal healthcare customers through DLA's Medical Supply Chain. The contract reflects AmerisourceBergen's established capability as a critical pharmaceutical distributor for federal medical procurement needs through its competitive performance record with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $97.5k | 7/31/25 |